Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

University of North Carolina at Chapel Hill

University of North Carolina at Chapel Hill in Chapel Hill, North Carolina, United States is listed as a site for 871 registered clinical trials, 212 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 871
Ongoing 212

This page covers the site record University of North Carolina at Chapel Hill in Chapel Hill, North Carolina, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the University of North Carolina at Chapel Hill report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 871 trials counted.

  • Phase 1 60 trials
  • Phase 1/2 37 trials
  • Phase 2 135 trials
  • Phase 2/3 16 trials
  • Phase 3 137 trials
  • Phase 4 34 trials
  • Not applicable 299 trials
  • Observational 152 trials
  • Expanded access 1 trial

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 212 trials
  • Completed 546 trials
  • Terminated 100 trials
  • Other 13 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 60

1996: 1 trials (Phase 3 1) 1997: 2 trials (Phase 3 1, Phase 1/2 1) 1998: 1 trials (Observational 1) 2000: 3 trials (Observational 1, Phase 3 2) 2001: 2 trials (Observational 1, Phase 3 1) 2002: 6 trials (Observational 1, Not applicable 1, Phase 3 2, Phase 2 2) 2003: 5 trials (Not applicable 2, Phase 2/3 1, Phase 2 2) 2004: 10 trials (Observational 2, Not applicable 2, Phase 3 2, Phase 2/3 1, Phase 2 1, Phase 1/2 1, Phase 1 1) 2005: 14 trials (Observational 2, Not applicable 3, Phase 3 4, Phase 2 2, Phase 1/2 1, Phase 1 2) 2006: 16 trials (Observational 5, Not applicable 3, Phase 3 4, Phase 2 2, Phase 1/2 2) 2007: 21 trials (Observational 3, Not applicable 6, Phase 4 2, Phase 3 5, Phase 2/3 1, Phase 2 2, Phase 1/2 2) 2008: 16 trials (Observational 6, Not applicable 4, Phase 4 2, Phase 3 2, Phase 2 2) 2009: 22 trials (Observational 2, Not applicable 6, Phase 4 1, Phase 3 7, Phase 2 2, Phase 1/2 1, Phase 1 3) 2010: 26 trials (Observational 5, Not applicable 2, Phase 3 6, Phase 2 5, Phase 1/2 4, Phase 1 4) 2011: 32 trials (Observational 9, Not applicable 1, Phase 4 1, Phase 3 6, Phase 2/3 1, Phase 2 10, Phase 1 4) 2012: 29 trials (Observational 6, Not applicable 10, Phase 4 1, Phase 3 2, Phase 2 8, Phase 1/2 1, Phase 1 1) 2013: 27 trials (Observational 7, Not applicable 7, Phase 3 6, Phase 2/3 1, Phase 2 3, Phase 1/2 1, Phase 1 2) 2014: 27 trials (Observational 4, Not applicable 7, Phase 4 1, Phase 3 7, Phase 2/3 1, Phase 2 3, Phase 1/2 1, Phase 1 3) 2015: 50 trials (Observational 9, Not applicable 14, Phase 4 1, Phase 3 11, Phase 2/3 1, Phase 2 9, Phase 1/2 1, Phase 1 4) 2016: 45 trials (Observational 12, Not applicable 8, Phase 4 9, Phase 3 7, Phase 2/3 1, Phase 2 4, Phase 1/2 3, Phase 1 1) 2017: 56 trials (Observational 4, Not applicable 19, Phase 4 2, Phase 3 7, Phase 2/3 2, Phase 2 14, Phase 1/2 4, Phase 1 4) 2018: 46 trials (Observational 5, Not applicable 21, Phase 3 10, Phase 2 6, Phase 1/2 2, Phase 1 2) 2019: 43 trials (Observational 8, Not applicable 21, Phase 3 1, Phase 2/3 1, Phase 2 8, Phase 1/2 1, Phase 1 3) 2020: 58 trials (Observational 13, Not applicable 24, Phase 3 7, Phase 2 9, Phase 1/2 1, Phase 1 4) 2021: 57 trials (Observational 9, Not applicable 21, Phase 4 2, Phase 3 10, Phase 2/3 2, Phase 2 8, Phase 1 5) 2022: 43 trials (Observational 8, Not applicable 16, Phase 4 3, Phase 3 5, Phase 2/3 1, Phase 2 4, Phase 1/2 3, Phase 1 3) 2023: 56 trials (Observational 9, Not applicable 31, Phase 4 2, Phase 3 3, Phase 2/3 1, Phase 2 5, Phase 1/2 3, Phase 1 2) 2024: 60 trials (Observational 8, Not applicable 31, Phase 4 4, Phase 3 8, Phase 2 4, Phase 1/2 2, Phase 1 3) 2025: 53 trials (Observational 8, Not applicable 19, Phase 3 9, Phase 2/3 1, Phase 2 10, Phase 1/2 1, Phase 1 5)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 40
2025 53
2024 60
2023 56
2022 43
2021 57
2020 58
2019 43
2018 46
2017 56

Showing 10 of 30 years.

Start your 14-day trial Email me all 30 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 2 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 871 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 183 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 485 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF